Titanium dioxide
Anthelios (titanium dioxide) is a small molecule pharmaceutical. Titanium dioxide was first approved as Anthelios 20 on 2006-10-05.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Combinations
Anthelios
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
derma pella luminous cream | unapproved drug other | 2023-06-20 |
la roche posay face body anthelios spf 60 melt in milk fast absorbing, velvety finish for all skin types with cell-oc shield xl | OTC monograph not final | 2022-12-29 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
46 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Coronary artery disease | D003324 | I25.1 | 1 | — | 1 | 5 | 1 | 8 | |
Ischemic stroke | D000083242 | 1 | 5 | 3 | 2 | — | 7 | ||
Inferior wall myocardial infarction | D056989 | EFO_1000983 | — | — | 1 | 5 | — | 6 | |
St elevation myocardial infarction | D000072657 | — | — | 1 | 2 | 2 | 5 | ||
Myocardial infarction | D009203 | EFO_0000612 | I21 | — | 1 | 1 | 2 | 1 | 5 |
Acute coronary syndrome | D054058 | EFO_0005672 | — | 1 | 2 | 1 | 1 | 5 | |
Percutaneous coronary intervention | D062645 | — | — | 1 | 2 | — | 3 | ||
Non-st elevated myocardial infarction | D000072658 | — | — | — | 1 | 1 | 2 | ||
Coronary disease | D003327 | — | — | — | 1 | — | 1 | ||
Balloon angioplasty coronary | D015906 | EFO_0003951 | — | — | — | 1 | — | 1 |
Show 2 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Unstable angina | D000789 | EFO_1000985 | I20.0 | — | 1 | 1 | — | — | 2 |
Stroke | D020521 | EFO_0000712 | I63.9 | — | 1 | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Respiratory insufficiency | D012131 | HP_0002093 | J96.9 | — | 1 | — | — | — | 1 |
Embolism and thrombosis | D016769 | — | 1 | — | — | — | 1 | ||
Viral pneumonia | D011024 | EFO_0007541 | J12.9 | — | 1 | — | — | — | 1 |
Subarachnoid hemorrhage | D013345 | EFO_0000713 | I60 | 1 | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Renal insufficiency | D051437 | HP_0000083 | N19 | 1 | — | — | — | — | 1 |
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | TITANIUM DIOXIDE |
INN | — |
Description | Titanium dioxide is a titanium oxide with the formula TiO2. A naturally occurring oxide sourced from ilmenite, rutile and anatase, it has a wide range of applications. It has a role as a food colouring. |
Classification | Small molecule |
Drug class | quaternary ammonium derivatives |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
PDB | — |
CAS-ID | 13463-67-7 |
RxCUI | — |
ChEMBL ID | CHEMBL1201136 |
ChEBI ID | 32234 |
PubChem CID | 26042 |
DrugBank | — |
UNII ID | — |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 27,812 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
2,369 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more